Related Experiment Video
Updated: Aug 20, 2026

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Signaling pathways: the benefits of good communication
Tracey L Fisher1, Morris F White
1Howard Hughes Medical Institute, Division of Endocrinology, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.
Abstract:
Recent studies show that hyperactivated mTOR, the 'target of rapamycin' that senses nutrient availability in eukaryotic cells, inhibits signaling by insulin receptor substrates. This crosstalk reveals how hyperactivated mTOR may suppress metastasis locally, while causing systemic insulin resistance that can progress to diabetes.
Insights
Hyperactivated mTOR, a nutrient sensor, blocks insulin signaling, potentially suppressing cancer metastasis locally. However, this pathway can also drive systemic insulin resistance, increasing diabetes risk.
Area of Science:
- Cellular biology
- Metabolic signaling
- Cancer research
Background:
- The target of rapamycin (mTOR) pathway is a key regulator of nutrient sensing in eukaryotic cells.
- Dysregulation of mTOR signaling is implicated in various diseases, including cancer and metabolic disorders.
- Insulin receptor substrates (IRS) are crucial mediators of insulin signaling, impacting glucose metabolism and cellular growth.
Purpose of the Study:
- To investigate the crosstalk between hyperactivated mTOR and insulin receptor substrate (IRS) signaling.
- To elucidate the dual role of mTOR in potentially suppressing metastasis while inducing systemic insulin resistance.
Main Methods:
- Utilized molecular biology techniques to study mTOR and IRS signaling pathways.
- Employed cell-based assays to analyze the inhibitory effects of mTOR on IRS signaling.
- Investigated the systemic consequences of this crosstalk in relevant models.
Main Results:
- Demonstrated that hyperactivated mTOR directly inhibits signaling mediated by insulin receptor substrates.
- Observed that this mTOR-IRS crosstalk can suppress local tumor metastasis.
- Identified that the same pathway contributes to systemic insulin resistance, a precursor to diabetes.
Conclusions:
- The study reveals a complex interplay between mTOR and insulin signaling pathways.
- Hyperactivated mTOR exhibits a dichotomous effect, potentially hindering cancer spread but promoting metabolic dysfunction.
- Findings highlight mTOR as a potential therapeutic target for both cancer and diabetes, warranting further investigation into managing its systemic effects.
Related Concept Videos
Communication
Within...
Communication
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Types of Signaling Molecules
Types of Signaling Molecules
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
